MYOCARDIAL INFARCTION TYPE 2. MYTH OR REALITY?
https://doi.org/10.20514/2226-6704-2016-6-2-34-41
Abstract
According to The Third Definition of Myocardial Infarction there are five types of myocardial infarction depending on pathogenesis. This review provides actual data about myocardial infarction type 2 mechanism including diagnosis management, epidemiological characteristic and patient prognosis. Previously published data shows discordant information about myocardial infarction type 2 frequency, treatment and diagnostic options. Our clinical observation illustrates these severities in diagnosis construction, disease feature in acute period in casual clinical practice.
About the Authors
V. V. Zhelnov
I.M. Sechenov First State Medical University
Russian Federation
Russian Federation
Chair of Internal medicine № 2,
Moscow
N. V. Dyatlov
I.M. Sechenov First State Medical University
Russian Federation
Russian Federation
Chair of Internal medicine № 2,
Moscow
L. I. Dvoretsky
I.M. Sechenov First State Medical University
Russian Federation
Russian Federation
Chair of Internal medicine № 2,
Moscow
References
1. Thygesen K, Alpert JS, Jaffe AS et al. Third universal definition of myocardial infarction. J Am Coll Cardiol 2012;60:1581–98
2. Schofer N, Hamm C, Katus HA et al. Comment the Third Universal definition of myocardial infarction of Community ESC / ACCF / AHA / WHF Task Force. Cardiologist (2014) 8: 65-71.
3. Joseph S. Alpert JS et al. Diagnostic and Therapeutic Implications of Type 2 Myocardial Infarction: Review and Commentary. American Journal of Medicine (2014) 127, 105-108
4. P O Collinson Type 2 Myocardial Infarction. Heart (2015);101(2):89-90.
5. Baron T. et al. Type 2 myocardial infarction in clinical practice. Heart (2015);101:101–106.
6. Third universal definition of myocardial infarction. Russian journal of cardiology 2013 2 (100) supplement 1. Internet source http://www.scardio.ru/content/Guidelines/Rek_infarct_2013.pdf
7. Yader S. et al. Supply/Demand Type 2 Myocardial Infarction. JACC Vol. 63, No. 20, 2014 2079–87.
8. Melberg T, Burman R, Dickstein K. The impact of the 2007 ESC/ACC/AHA/WHF Universal definition on the incidence and classification of acute myocardial infarction: A retrospective cohort study. Int J Cardiol 2010;139:228–33.
9. Javed U, Aftab W, Ambrose JA, et al. Frequency of elevated troponin I and diagnosis of acute myocardial infarction. Am J Cardiol 2009;104:9–13.
10. Saaby L, Poulsen TS, Hosbond S, et al. Classification of myocardial infarction: frequency and features of type 2 myocardial infarction. Am J Med 2013;126:789–97.
11. Gonzalez MA, Eilen DJ, Marzouq RA, et al.; Multidisciplinary Atherosclerosis Prevention Program. The universal classification is an independent predictor of long-term outcomes in acute myocardial infarction. Cardiovasc Revasc Med 2011;12:35–40.
12. Kanderian AS, Francis GS. Cardiac troponins and chronic kidney disease. Kidney Int 2006;69:1112– 4. 62.
13. Wang AY, Lai KN. Use of cardiac biomarkers in end-stage renal disease. J Am Soc Nephrol 2008;19:1643–52
14. Januzzi JL Jr, Filippatos G, Nieminen M et al Troponin elevation in patients with heart failure: on behalf of the third Universal Definition of Myocardial Infarction Global Task Force: Heart Failure Section. Eur Heart J. 2012;33(18):2265-71.
15. Nagarajan V, Hernandez AV, Tang WH. Prognostic value of cardiac troponin in chronic stable heart failure: a systematic review. Heart. 2012; 98(24):1778-86
16. Rubin J, Matsushita K, Ballantyne CM, Hoogeveen R, Coresh J, Selvin E. Chronic hyperglycemia and subclinical myocardial injury. J Am Coll Cardiol. 2012; 59(5):484-489.
17. Jaffe AS. Chasing troponin: how low can you go if you can see the rise? J Am Coll Cardiol 2006;48;1763-1764
18. Thygesen K, Alpert JS, White HD, Joint ESC/ACCF/AHA/WHF Task force for the Redefinition of Myocardial infarction. Universal definition of myocardial infarction. Eur Heart J 2007;28;2525-2538.
19. Jaffe AS, Babuin L, Apple FS. Biomarkers in acute cardiac disease. J Am Coll Cardiol 2006;48:1-11.
20. White HD. Pathobiology of troponin elevation. J Am Coll Cardiol 2011;27:2406-2408.
21. Masson S, Latini R, Mureddu GF et al. High-sensitivity cardiac troponin T for detection of subtle abnormalities of cardiac phenotype in a general population of elderly individuals. J Intern Med. 2013 ;273(3):306-17
22. Yader S., Sarah E. et al. Cardiac troponin changes to distinguish type 1 and type 2 myocardial infarction and 180-day mortality risk. European Heart Journal: Acute Cardiovascular Care 06/2014; 3(4)
23. Bertrand ME, LaBlanche JM, Tilmant PY, et al. Frequency of provoked coronary arterial spasm in 1089 consecutive patients undergoing coronary arteriography. Circulation 1982;65:1299 –306.
24. Suwaidi JA, Hamasaki S, Higano ST et al. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 2000; 101:948 –54. 28.
25. Bugiardini R, Manfrini O, Pizzi C et al. Endothelial function predicts future development of coronary artery disease: a study on women with chest pain and normal angiograms. Circulation 2004;109:2518 –23.
26. Ambrose JA, Loures-Vale A, Javed U, et al. Angiographic correlates in Type 1 and 2 MI by the universal definition. JACC Cardiovasc Imaging 2012;5:463–4.
Review
For citations:
Zhelnov V.V., Dyatlov N.V., Dvoretsky L.I. MYOCARDIAL INFARCTION TYPE 2. MYTH OR REALITY? The Russian Archives of Internal Medicine. 2016;6(2):34-41. (In Russ.) https://doi.org/10.20514/2226-6704-2016-6-2-34-41
Views:
1599
Email this article 